Alternatives to Moleculent

Moleculent is a Biotech tool: mapping cell-cell communication at scale in human tissue. Here are the 49 closest alternatives, compared on pricing, features and what real users say.

Moleculent profile More Biotech alternatives

The 20 closest Biotech companies to Moleculent

Enterome
Not rated
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Visit site
Matterworks
Not rated
Visit site
Caris Life Sciences
Not rated
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Visit site
Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site
BeiGene
Not rated
A global oncology company developing and commercializing innovative cancer treatments.
Visit site
BenchSci
2.0 out of 5 (2)
AI-powered platform for understanding disease biology and accelerating drug discovery.
Visit site
Manifold Bio
Not rated
AI-guided drug discovery platform for tissue-targeted medicines.
Visit site
Synthace
Not rated
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Visit site
Lexeo Therapeutics
3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
Deep Genomics
Not rated
AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
Visit site
Profluent Bio
Not rated
AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.
Visit site
Moderna
2.5 out of 5 (2)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
Guardant Health
Not rated
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Visit site
Hexagon Bio
Not rated
Developing novel therapeutics by understanding the complex interplay of biological systems.
Visit site
Atomic-AI
Not rated
AI platform for drug discovery and development, accelerating research with advanced computational tools.
Visit site
Cellcolabs
Not rated
AI-powered platform for personalized cell therapy development and manufacturing.
Visit site
Ultragenyx
Not rated
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
Visit site
Tenaya Therapeutics
Not rated
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Visit site
Avidity Biosciences
Not rated
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Visit site
Adaptam Therapeutics
Not rated
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
Visit site

Company	Rating	Visit
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.	Not rated	Visit site
Matterworks	Not rated	Visit site
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.	Not rated	Visit site
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.	Not rated	Visit site
BenchSciAI-powered platform for understanding disease biology and accelerating drug discovery.	2.0 out of 5 (2)	Visit site
Manifold BioAI-guided drug discovery platform for tissue-targeted medicines.	Not rated	Visit site
SynthaceSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	3.0 out of 5 (1)	Visit site
Deep GenomicsAI-powered biotechnology company developing RNA therapeutics for genetic diseases.	Not rated	Visit site
Profluent BioAI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.	Not rated	Visit site
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.5 out of 5 (2)	Visit site
Guardant HealthGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.	Not rated	Visit site
Hexagon BioDeveloping novel therapeutics by understanding the complex interplay of biological systems.	Not rated	Visit site
Atomic-AIAI platform for drug discovery and development, accelerating research with advanced computational tools.	Not rated	Visit site
CellcolabsAI-powered platform for personalized cell therapy development and manufacturing.	Not rated	Visit site
UltragenyxBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.	Not rated	Visit site
Tenaya TherapeuticsBiotechnology company developing gene therapies and regenerative medicine for heart disease.	Not rated	Visit site
Avidity BiosciencesClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.	Not rated	Visit site
Adaptam TherapeuticsDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Moleculent profile.

Sponsored rows are paid and labelled. Advertise on this page